Jay Bradner

Jay Bradner

Company: Novartis Institutes for Biomedical Research

Job title: President


Targeted Protein Degradation: Chemical Biology to Therapeutics 12:00 pm

The increasingly atomic resolution of human biology presents an unprecedented opportunity for the innovation of definitive medicines for life-threatening diseases. Still, many well-defined, high-value protein targets remain “undruggable” – beyond the limits of historical efforts in ligand discovery Discussing progress in the field of targeted protein degradation (TPD), inspired by natural products and advances in…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.